Essential Hypertension

Cardiovascular·MeSH: Essential Hypertension

Prevalence

47000.0 / 100K

Incidence

3000.0 / 100K/yr

4 drugs in development·2 companies·4 clinical trials

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Essential Hypertension?

BioSniper tracks 4 drugs in development for Essential Hypertension across 2 companies.

How many clinical trials target Essential Hypertension?

There are 4 clinical trials targeting Essential Hypertension tracked by BioSniper.

What is the prevalence of Essential Hypertension?

The estimated prevalence of Essential Hypertension is approximately 47000.0 per 100,000 population.

Deep-dive into Essential Hypertension

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Essential Hypertension — Drugs in Development & Clinical Trials | BioSniper